BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24909296)

  • 1. Targeting SIM2-s decreases glioma cell invasion through mesenchymal--epithelial transition.
    Su Y; Wang J; Zhang X; Shen J; Deng L; Liu Q; Li G
    J Cell Biochem; 2014 Nov; 115(11):1900-7. PubMed ID: 24909296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-200a impairs glioma cell growth, migration, and invasion by targeting SIM2-s.
    Su Y; He Q; Deng L; Wang J; Liu Q; Wang D; Huang Q; Li G
    Neuroreport; 2014 Jan; 25(1):12-7. PubMed ID: 24162743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the bHLH transcriptional networks by mutated E proteins in experimental glioma.
    Beyeler S; Joly S; Fries M; Obermair FJ; Burn F; Mehmood R; Tabatabai G; Raineteau O
    Stem Cells; 2014 Oct; 32(10):2583-95. PubMed ID: 24965159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. System analysis identifies distinct and common functional networks governed by transcription factor ASCL1, in glioma and small cell lung cancer.
    Donakonda S; Sinha S; Dighe SN; Rao MRS
    Mol Biosyst; 2017 Jul; 13(8):1481-1494. PubMed ID: 28742165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of drebrin in glioma migration and invasion.
    Terakawa Y; Agnihotri S; Golbourn B; Nadi M; Sabha N; Smith CA; Croul SE; Rutka JT
    Exp Cell Res; 2013 Feb; 319(4):517-28. PubMed ID: 23201135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy.
    Xu H; Rahimpour S; Nesvick CL; Zhang X; Ma J; Zhang M; Zhang G; Wang L; Yang C; Hong CS; Germanwala AV; Elder JB; Ray-Chaudhury A; Yao Y; Gilbert MR; Lonser RR; Heiss JD; Brady RO; Mao Y; Qin J; Zhuang Z
    Oncotarget; 2015 May; 6(14):11882-93. PubMed ID: 25957416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells.
    Aleman MJ; DeYoung MP; Tress M; Keating P; Perry GW; Narayanan R
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12765-70. PubMed ID: 16129820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple roles of single-minded 2 in esophageal squamous cell carcinoma and its clinical implications.
    Tamaoki M; Komatsuzaki R; Komatsu M; Minashi K; Aoyagi K; Nishimura T; Chiwaki F; Hiroki T; Daiko H; Morishita K; Sakai Y; Seno H; Chiba T; Muto M; Yoshida T; Sasaki H
    Cancer Sci; 2018 Apr; 109(4):1121-1134. PubMed ID: 29427302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single minded 2-s (SIM2-s) gene is expressed in human GBM cells and involved in GBM invasion.
    He Q; Li G; Su Y; Shen J; Liu Q; Ma X; Zhao P; Zhang J
    Cancer Biol Ther; 2010 Mar; 9(6):430-6. PubMed ID: 20448453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
    Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
    Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of single-minded 2 to hyperglycaemia-induced neurotoxicity.
    Wang X; Song Y; Chen L; Zhuang G; Zhang J; Li M; Meng XF
    Neurotoxicology; 2013 Mar; 35():106-12. PubMed ID: 23333261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GOLPH3 regulates the migration and invasion of glioma cells though RhoA.
    Zhou X; Zhan W; Bian W; Hua L; Shi Q; Xie S; Yang D; Li Y; Zhang X; Liu G; Yu R
    Biochem Biophys Res Commun; 2013 Apr; 433(3):338-44. PubMed ID: 23500462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion.
    Luk SK; Piekorz RP; Nürnberg B; Tony To SS
    Eur J Cancer; 2012 Jan; 48(1):149-57. PubMed ID: 22079609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome.
    Tran NL; McDonough WS; Savitch BA; Fortin SP; Winkles JA; Symons M; Nakada M; Cunliffe HE; Hostetter G; Hoelzinger DB; Rennert JL; Michaelson JS; Burkly LC; Lipinski CA; Loftus JC; Mariani L; Berens ME
    Cancer Res; 2006 Oct; 66(19):9535-42. PubMed ID: 17018610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
    Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
    J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of annexin 2 decreases migration of human glioma cells in vitro.
    Tatenhorst L; Rescher U; Gerke V; Paulus W
    Neuropathol Appl Neurobiol; 2006 Jun; 32(3):271-7. PubMed ID: 16640645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the transcription factor SIM2 in prostate cancer.
    Lu B; Asara JM; Sanda MG; Arredouani MS
    PLoS One; 2011; 6(12):e28837. PubMed ID: 22174909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bHLH/Per-Arnt-Sim transcription factor SIM2 regulates muscle transcript myomesin2 via a novel, non-canonical E-box sequence.
    Woods S; Farrall A; Procko C; Whitelaw ML
    Nucleic Acids Res; 2008 Jun; 36(11):3716-27. PubMed ID: 18480125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of SIM2-s protein is a novel marker of aggressive prostate cancer.
    Halvorsen OJ; Rostad K; Øyan AM; Puntervoll H; Bø TH; Stordrange L; Olsen S; Haukaas SA; Hood L; Jonassen I; Kalland KH; Akslen LA
    Clin Cancer Res; 2007 Feb; 13(3):892-7. PubMed ID: 17289882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.